Numerous studies have shown that UBE2C overexpression was correlated with poor prognosis and regulated the malignant biological process of various tumors, including endometrial cancer, breast cancer and ovarian cancer 33, 34, 35. This evidence concerns the gene UBE2C and ovarian cancer.